Organogenesis Holdings (ORGO) Tax Provisions (2017 - 2026)

Organogenesis Holdings' Tax Provisions history runs 10 years deep, the most recent figure standing at -$15.3 million for Q1 2026.

• On a quarterly basis, Tax Provisions fell 120.71% year-over-year to -$15.3 million in Q1 2026; TTM through Mar 2026 was -$3.8 million, a 54.05% increase from a year earlier, with the FY2025 full-year figure at $4.5 million, up 223.58% from the prior year.
• Tax Provisions declined to -$15.3 million in Q1 2026 per ORGO's latest filing, from $14.3 million in the prior quarter.
• Across five years, Tax Provisions topped out at $14.3 million in Q4 2025 and bottomed at -$15.3 million in Q1 2026.
• The 5-year median for Tax Provisions is $45000.0 (2022), against an average of -$368647.1.
• Across the five-year window, Tax Provisions surged 1075.38% in 2022 and tumbled 3784.44% in 2023, its largest moves.
• Year by year, Tax Provisions stood at $1.3 million in 2022, then sank by 355.52% to -$3.2 million in 2023, then jumped by 179.63% to $2.6 million in 2024, then soared by 455.12% to $14.3 million in 2025, then slumped by 206.95% to -$15.3 million in 2026.
• Per Business Quant, the three latest ORGO Tax Provisions figures stand at -$15.3 million (Q1 2026), $14.3 million (Q4 2025), and -$407000.0 (Q3 2025).